TREM2 in CNS homeostasis and neurodegenerative disease

Molecular Neurodegeneration
Meghan M PainterGuojun Bu

Abstract

Myeloid-lineage cells accomplish a myriad of homeostatic tasks including the recognition of pathogens, regulation of the inflammatory milieu, and mediation of tissue repair and regeneration. The innate immune receptor and its adaptor protein—triggering receptor expressed on myeloid cells 2 (TREM2) and DNAX-activating protein of 12 kDa (DAP12)—possess the ability to modulate critical cellular functions via crosstalk with diverse signaling pathways. As such, mutations in TREM2 and DAP12 have been found to be associated with a range of disease phenotypes. In particular, mutations in TREM2 increase the risk for Alzheimer's disease and other neurodegenerative disorders. The leading hypothesis is that microglia, the resident immune cells of the central nervous system, are the major myeloid cells affected by dysregulated TREM2-DAP12 function. Here, we review how impaired signaling by the TREM2-DAP12 pathway leads to altered immune responses in phagocytosis, cytokine production, and microglial proliferation and survival, thus contributing to disease pathogenesis.

References

Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Apr 16, 1998·American Journal of Human Genetics·P PekkarinenL Peltonen
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BouchonM Colonna
Jul 3, 2002·Nature Reviews. Immunology·Martin Turner, Daniel D Billadeau
Feb 6, 2003·The Journal of Clinical Investigation·Tomonori KaifuToshiyuki Takai
May 31, 2003·Nature Reviews. Immunology·Marco Colonna
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael R DawsWilliam E Seaman
Sep 15, 2004·The Journal of Experimental Medicine·Marina CellaWojciech Swat
Feb 25, 2005·The Journal of Experimental Medicine·Kazuya TakahashiHarald Neumann
May 17, 2005·Nature Immunology·Jessica A HamermanLewis L Lanier
Jun 27, 2006·Nature Medicine·Randall J BatemanDavid M Holtzman
Sep 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isaiah R TurnbullMarco Colonna
Jan 16, 2007·Nature Reviews. Immunology·Isaiah R Turnbull, Marco Colonna
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Silke WalterKlaus Fassbender
May 31, 2008·Journal of Neuroinflammation·Jing-Ji JinKen-Ichiro Fukuchi
Jan 28, 2009·The Journal of Cell Biology·Elsa-Noah N'DiayeWilliam E Seaman
Mar 24, 2009·Journal of Neurochemistry·Christine L HsiehWilliam E Seaman
Apr 14, 2009·Neurobiology of Aging·Amy W ButlerJohn F Powell
Jun 19, 2009·Nature Immunology·Daniel W McVicar, Giorgio Trinchieri
Sep 25, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Erin G Reed-GeaghanGary E Landreth
Oct 26, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Harro SeelaarJohn C van Swieten
Oct 1, 2011·European Journal of Immunology·Hiroaki Ito, Jessica A Hamerman
Oct 26, 2011·Nature Reviews. Immunology·Kaoru Saijo, Christopher K Glass
Nov 16, 2012·The New England Journal of Medicine·Thorlakur JonssonKari Stefansson
Nov 16, 2012·The New England Journal of Medicine·Rita GuerreiroUNKNOWN Alzheimer Genetic Analysis Group
Nov 16, 2012·The New England Journal of Medicine·Harald Neumann, Mark J Daly
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu

❮ Previous
Next ❯

Citations

Jun 2, 2016·Journal of Neurochemistry·Katrin I AndreassonLinda J Van Eldik
Nov 5, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jia ChengXiaoFen Chen
Mar 23, 2017·Journal of Neuroinflammation·Charlotte JendresenLars N G Nilsson
Nov 28, 2016·Molecular Neurobiology·Marta SochockaJerzy Leszek
Sep 4, 2016·Acta Neuropathologica Communications·Daniel W SirkisJennifer S Yokoyama
Jan 13, 2018·The Journal of Experimental Medicine·Wilbur M SongMarco Colonna
Dec 15, 2017·Open Biology·Georgia R Frost, Yue-Ming Li
Jan 11, 2018·Biomolecules & Therapeutics·Yeon-Joo Jung, Won-Suk Chung
Feb 28, 2018·Alzheimer's Research & Therapy·Frederic BrosseronMichael T Heneka
Jul 4, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kevin BarangerPhilippe Benech
Aug 16, 2018·Neurology. Genetics·Kotaro OgakiOwen A Ross
Aug 3, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ying GuoHaiyan Lou
Feb 18, 2017·The Journal of Experimental Medicine·Li ZhongGuojun Bu
Apr 30, 2017·Journal of Alzheimer's Disease : JAD·Michael Malek-AhmadiElliott J Mufson
Jun 9, 2017·Molecular Brain·Rong WuYamei Tang
Aug 16, 2018·Frontiers in Immunology·Marissa L DubbelaarErik W G M Boddeke
Mar 19, 2019·Journal of Alzheimer's Disease : JAD·Sheng-Lan ZhouJin-Tai Yu
Apr 18, 2017·Immunity & Ageing : I & a·William GalbavyMario J Rebecchi
Dec 28, 2018·International Journal of Molecular Sciences·Cody M WolfeRadosveta Koldamova
Oct 16, 2016·Acta Neuropathologica·Elisabeth Sanchez-MejiasJavier Vitorica
Aug 16, 2019·Science Translational Medicine·Yuetiva DemingCarlos Cruchaga
Jul 22, 2017·Frontiers in Aging Neuroscience·Ana I RamirezJosé M Ramírez
Apr 4, 2018·Experimental & Molecular Medicine·Yingjun ZhaoHuaxi Xu
Mar 14, 2020·Journal of Neurotrauma·Zoe M TappOlga N Kokiko-Cochran
Dec 12, 2018·Frontiers in Aging Neuroscience·Honghua ZhengYun-Wu Zhang
Dec 18, 2020·Frontiers in Cellular Neuroscience·Gemma ManichBernardo Castellano
Feb 9, 2021·Neurochemistry International·Juan José Triviño, Rommy von Bernhardi
Mar 7, 2021·International Journal of Molecular Sciences·Natália Ferreira MendesEliana Pereira de Araújo

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleotide exchange
lavage
transmission electron microscopy

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.